Constellation Energy Corporation (CEG)

Constellation Energy's stock has slipped over the past month, down 10.19%, and sits 29.70% below its 52-week high of $380.78. The price is at $267.69, just above the 20-day EMA of $262.25 and below both the 50-day SMA of $269.87 and the 200-day SMA of $278.54. The sell-side remains constructive: 21 of 25 analysts rate the stock Buy or Strong Buy, and none rate it Sell. The central question for holders is whether a business growing revenue faster than its sector can pull the price back above its moving averages.

The stock fell 3.04% in its last session. Over one month it is down 10.19%, and over one year it is down 25.83%. Shorter returns are mixed: the stock is up 1.63% over one week, while its 3.83% decline over three months and 8.82% decline over six months place it under pressure on a longer view. The price is 2.07% above its 20-day EMA but 0.81% below its 50-day SMA and 3.89% below its 200-day SMA. The 50-day SMA sits 3.11% below the 200-day SMA, which means the medium-term averages have not yet turned upward. The 14-day RSI of 51.8 is in the neutral zone, and the MACD line is negative, so momentum has not confirmed a turn.

Constellation has beaten the EPS estimate in three of the last five reports. The August 6, 2026 report was the most recent beat, with EPS of $2.55 against an estimate of $2.28, a gap of 11.84%. Yet the share price fell 1.52% in the first session after that report. The November 7, 2025 report was a miss, with EPS of $3.04 against $3.12, and the stock rose 2.02% the next session. Two of the three beats were followed by a lower share price, so investors have been judging the company on guidance and expectations rather than on the headline number alone.

The trailing P/E of 26.17 is 14.8% above the sector median of 22.8, which places the stock broadly in line with peers despite the premium. Revenue grew 23.00% in the latest quarter year on year, against a sector median of 4.1%, and the net profit margin is 11.08%. Return on equity of 15.06% is above the sector median of 9.6%, and debt-to-equity of 0.76 keeps the balance sheet manageable. The trailing dividend yield is 0.62%, with an annual dividend of $1.67 per share.

Insiders have made one open-market purchase worth $418K in the last 18 months and no sales, which is a modest sign of confidence from people closest to the company. On the analyst side, 21 of 25 analysts rate the stock Buy or Strong Buy, with 4 at Hold and none at Sell. Recent actions were all reiterations or initiations at a buy-type rating: Morgan Stanley on October 30, CIBC and Wells Fargo on October 28, TD Cowen and Barclays on October 27, and HSBC starting coverage at Buy on October 22, 2026. Three months ago, 20 of 23 ratings were buys, so the analyst base has held its view through the recent decline.

The base case is a stock that stays in its current range while it works back toward its moving averages. The price needs to close above the 50-day SMA at $269.87 and then the 200-day SMA at $278.54 before the trend can be called repaired. Analysts' estimates point to EPS rising from $12.22 this year to $13.40 next year, a 9.7% increase, which is the kind of earnings growth that could support a rerating if it is delivered. The median 12-month analyst target is $345.00, with a range from $238.00 to $399.00. The lower end of that range sits below the current price, so the spread of analyst views is wide. A break below the 20-day EMA at $262.25 would bring the 52-week low of $228.63 into view and would weaken the case for the current analyst optimism. Because the stock's typical daily move is 4.26%, short-term swings of that size are normal and do not on their own change the picture.

Support sits first at the 20-day EMA of $262.25, the nearest level below the price, which the stock has held in recent sessions. Below that, the 52-week low of $228.63 is the next floor and marks the bottom of the past year's trading range. Resistance starts at the 50-day SMA of $269.87, a short distance above the price and the first level a rally would need to clear. The 200-day SMA of $278.54 is the next barrier, and it is the average that would have to be reclaimed for the long-term trend to turn. The 52-week high of $380.78 is the far ceiling and would require a substantial rerating.